Prenatal Endotoxemia and Placental Drug Transport in The Mouse: Placental Size-Specific Effects

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Bloise, Enrrico ^a   Bhuiyan, Manzerul ^a   Audette, Melanie C ^a   Petropoulos, Sophie ^b   Javam, Mohsen ^a   Gibb, William ^c   Matthews, Stephen G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; EMBRYO; ENDOTOXEMIA; FEMALE; FETUS OUTCOME; GESTATIONAL AGE; HEART MUSCLE; IMMUNE RESPONSE; LONG TERM EXPOSURE; MALE; MATERNAL PLASMA; MOUSE; NONHUMAN; PLACENTA CIRCULATION; PLACENTA DEVELOPMENT; PLACENTA WEIGHT; PRENATAL ENDOTOXEMIA; PRENATAL EXPOSURE; PROTEIN EXPRESSION; PROTEIN TRANSPORT;

ANIMALS; BIOLOGICAL TRANSPORT; BLOTTING, WESTERN; CARDIOTONIC AGENTS; CYTOKINES; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MULTIPLE; ENDOTOXEMIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS; GENES, MDR; GESTATIONAL AGE; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; P-GLYCOPROTEIN; PLACENTA; PREGNANCY; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TISSUE DISTRIBUTION;

MUS;

EID: 84878892324     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065728     Document Type: Article

References (47)

1. Medzhitov R, (2010) Inflammation 2010: new adventures of an old flame. Cell 19: 771-776.
2. Gulati S, Bhatnagar S, Raghunandan C, Bhattacharjee J, (2012) Interleukin-6 as a predictor of subclinical chorioamnionitis in preterm premature rupture of membranes. Am J Reprod Immunol 67: 235-240.
3. Challis JR, Lockwood CJ, Myatt L, Norman JE, Strauss JF 3rd, et al (2009) Inflammation and pregnancy. Reprod Sci 16: 206-215.
4. Willoughby RE Jr, Nelson KB, (2002) Chorioamnionitis and brain injury. Clin Perinatol 29: 603-621.
5. Al-Bataineh MM, van der Merwe D, Schultz BD, Gehring R, (2010) Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells. Biopharm Drug Dispos 31: 506-515.
6. Wang JH, Scollard DA, Teng S, Reilly RM, Piquette-Miller M, (2005) Detection of P-glycoprotein activity in endotoxemic rats by 99mTc-sestamibi imaging. J Nucl Med 46: 1537-1545.
7. Petrovic V, Wang JH, Piquette-Miller M, (2008) Effect of endotoxin on the expression of placental drug transporters and glyburide disposition in pregnant rats. Drug Metab Dispos 36: 1944-1950.
8. Iqbal M, Audette MC, Petropoulos S, Gibb W, Matthews SG, (2012) Placental drug transporters and their role in fetal protection. Placenta 33: 137-142.
9. Iqbal M, Ho HL, Petropoulos S, Moisiadis VG, Gibb W, et al. (2012) Pro-Inflammatory Cytokine Regulation of P-glycoprotein in the Developing Blood-Brain Barrier. PLoS One 7(8): e43022.
10. Mason CW, Buhimschi IA, Buhimschi CS, Dong Y, Weiner CP, et al. (2011) ATP-binding cassette transporter expression in human placenta as a function of pregnancy condition. Drug Metab Dispos 39: 1000-1007.
11. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, et al. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 84: 7735-7738.
12. Zhou SF, (2008) Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 38: 802-832.
13. Kalabis GM, Kostaki A, Andrews MH, Petropoulos S, Gibb W, et al. (2005) Multidrug resistance phosphoglycoprotein (ABCB1) in the mouse placenta: fetal protection. Biol Reprod 73: 591-597.
14. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, et al. (2006) Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27: 602-609.
15. Yeboah D, Sun M, Kingdom J, Baczyk D, Lye SJ, et al. (2006) Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. Can J Physiol Pharmacol 84: 1251-1258.
16. Kalabis GM, Petropoulos S, Gibb W, Matthews SG, (2007) Breast cancer resistance protein (Bcrp1/Abcg2) in mouse placenta and yolk sac: ontogeny and its regulation by progesterone. Placenta 28: 1073-1081.
17. Petropoulos S, Gibb W, Matthews SG, (2010) Effect of glucocorticoids on regulation of placental multidrug resistance phosphoglycoprotein (P-gp) in the mouse. Placenta 31: 803-810.
18. Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow SK, Othman M, et al. (2011) Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol 186: 1799-1808.
19. Burton GJ, Fowden AL, (2012) Review: The placenta and developmental programming: balancing fetal nutrient demands with maternal resource allocation. Placenta 33Suppl:S23-27.
20. Desforges M, Sibley CP, (2010) Placental nutrient supply and fetal growth. Int J Dev Biol 54: 377-390.
21. Coan PM, Angiolini E, Sandovici I, Burton GJ, Constância M, et al. (2008) Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in mice. J Physiol 15: 4567-4576.
22. Bloise E, Lin W, Liu X, Simbulan R, Kolahi KS, et al. (2012) Impaired placental nutrient transport in mice generated by in vitro fertilization. Endocrinology 153: 3457-3467.
23. Petropoulos S, Kalabis GM, Gibb W, Matthews SG, (2007) Functional changes of mouse placental multidrug resistance phosphoglyco- protein (ABCB1) with advancing gestation and regulation by progesterone. Reprod Sci 14: 321-328.
24. Malassiné A, Frendo JL, Evain-Brion DA, (2003) Comparison of placental development and endocrine functions between the human and mouse model. Hum Reprod Update 9: 531-539.
25. Schinkel AH, Wagenaar E, vanDeemter L, Mol CAAM, Borst P, (1995) Absence of the Mdr1A P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporine-A. J Clin Invest 96: 1698-1705.
26. de Lannoy IA, Silverman M, (1992) The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin. Biochem Biophys Res Commun 189: 551-557.
27. Pfaffl MW, (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29(9): e45.
28. Drewlo S, Levytska K, Kingdom J, (2012) Revisiting the housekeeping genes of human placental development and insufficiency syndromes. Placenta 2012 33: 952-954.
29. Audette MC, Challis JR, Jones RL, Sibley CP, Matthews SG, (2011) Antenatal dexamethasone treatment in midgestation reduces system A-mediated transport in the late-gestation murine placenta. Endocrinology 152: 3561-3570.
30. Jones KL, Mansell A, Patella S, Scott BJ, Hedger MP, et al. (2007) Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia. Proc Natl Acad Sci U S A 104: 16239-16244.
31. Menon R, Taylor RN, Fortunato SJ, (2010) Chorioamnionitis-a complex pathophysiologic syndrome. Placenta 31: 113-120.
32. Koga K, Mor G, (2010) Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol 63: 587-600.
33. Kumazaki K, Nakayama M, Yanagihara I, Suehara N, Wada Y, (2004) Immunohistochemical distribution of Toll-like receptor 4 in term and preterm human placentas from normal and complicated pregnancy including chorioamnionitis. Hum Pathol 35: 47-54.
34. Ma Y, Mor G, Abrahams VM, Buhimschi IA, Buhimschi CS, et al. (2006) Alterations in syncytiotrophoblast cytokine expression following treatment with lipopolysaccharide. Am J Reprod Immunol 55: 12-18.
35. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ, (2002) Typhoid fever. N Engl J Med 347: 1770-1782.
36. Omanwar S, Rizvi MR, Kathayat R, Sharma BK, Pandey GK, et al. (2004) A rabbit model of non-cirrhotic portal hypertension by repeated injections of E.coli through indwelling cannulation of the gastrosplenic vein. Hepatobiliary Pancreat Dis Int 3: 417-422.
37. Griffin AJ, McSorley SJ, (2011) Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda. Mucosal Immunol 4: 371-382.
38. Dopp JM, Moran JJ, Abel NJ, Wiegert NA, Cowgill JB, et al. (2009) Influence of intermittent hypoxia on myocardium and hepatic P-glycoprotein expression in a rodent model. Pharmacotherapy 29: 365-372.
39. Tomita M, Takizawa Y, Kishimoto H, Hayashi M, (2009) Effect of intestinal ischaemia/reperfusion on P-glycoprotein-mediated ileal excretion of rhodamine 123 in the rat. J Pharm Pharmacol 61: 1319-1324.
40. Chong Y, Wang T, Wang W, Zhang L, Li C, et al. (2012) Down-regulation of P-glycoprotein expression contributes to an increase in Danshensu accumulation in the cerebral ischemia/reperfusion brain. Mol Med Report 5: 812-816.
41. Evseenko DA, Paxton JW, Keelan JA, (2007) Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 35: 595-601.
42. Kaukola T, Satyaraj E, Patel DD, Tchernev VT, Grimwade BG, et al. (2004) Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol 2004 55: 186-94.
43. Bloise E, Torricelli M, Novembri R, Borges LE, Carrarelli P, et al. (2010) Heat-killed Lactobacillus rhamnosus GG modulates urocortin and cytokine release in primary trophoblast cells. Placenta 31: 867-872.
44. Novembri R, Torricelli M, Bloise E, Conti N, Galeazzi LR, et al. (2011) Effects of urocortin 2 and urocortin 3 on IL-10 and TNF-α expression and secretion from human trophoblast explants. Placenta 32: 969-974.
45. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999 11: 443-451.
46. Bayraktar M, Peltier M, Vetrano A, Arita Y, Gurzenda E, et al. (2009) IL-10 modulates placental responses to TLR ligands. Am J Reprod Immunol 62: 390-399.
47. Torricelli M, Voltolini C, Bloise E, Biliotti G, Giovannelli A, et al. (2009) Urocortin increases IL-4 and IL-10 secretion and reverses LPS-induced TNF-alpha release from human trophoblast primary cells. Am J Reprod Immunol 62: 224-231.